News
Advertisement
Advertisement
George Clinical's Managing Director discusses the concern biopharma companies have with CFDA's slow drug and medical device approvals.
Advertisement
This article discusses the adoption of RBQM in academic settings and the lessons that were learned.
Advertisement
A review of a recent FSP in which the CRO partner assumed clinical monitoring and site support responsibility for more than 50 ongoing trials.
Click the title above to open the Applied Clinical Trials September/October 2017 issue in an interactive PDF format.
The National Institutes of Health (NIH) focuses on developing strategies that will encourage further research to support safe and effective therapies for pregnant and lactating women.
A look at the results of the recently completed project, which aimed to develop an holistic monitoring system via process integration to more effectively control clinical trial risks beyond isolated RBM strategies.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
2
Why Clinical Trials Are at a Crossroads and How Site Networks Are the Key to Success
3
Everything to Know About FDA’s Push Towards Radical Transparency in 2025
4
Phase IV Trial Shows Strong Immune Response from Moderna’s Updated Spikevax Against LP.8.1 Variant of COVID-19
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
